107 related articles for article (PubMed ID: 12632104)
41. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
[TBL] [Abstract][Full Text] [Related]
42. Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma.
Kriegl L; Jung A; Engel J; Jackstadt R; Gerbes AL; Gallmeier E; Reiche JA; Hermeking H; Rizzani A; Bruns CJ; Kolligs FT; Kirchner T; Göke B; De Toni EN
Clin Cancer Res; 2010 Nov; 16(22):5529-38. PubMed ID: 20889918
[TBL] [Abstract][Full Text] [Related]
43. [Antitumor effects of soluble TRAIL in human hepatocellular carcinoma].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhao YZ; Wang SF
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):116-9. PubMed ID: 12795833
[TBL] [Abstract][Full Text] [Related]
44. Expression of functional CD40 in human hepatocellular carcinoma.
Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
[TBL] [Abstract][Full Text] [Related]
45. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.
Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Kang CS; Kim KM; Jang JJ; Nam SW; Lee JY; Yoo NJ
Oncogene; 2001 Jan; 20(3):399-403. PubMed ID: 11313970
[TBL] [Abstract][Full Text] [Related]
46. Tissue distribution of the death ligand TRAIL and its receptors.
Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
[TBL] [Abstract][Full Text] [Related]
47. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.
Janssen HL; Higuchi H; Abdulkarim A; Gores GJ
J Hepatol; 2003 Sep; 39(3):414-20. PubMed ID: 12927928
[TBL] [Abstract][Full Text] [Related]
49. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
Chung GE; Yoon JH; Myung SJ; Lee JH; Lee SH; Lee SM; Kim SJ; Hwang SY; Lee HS; Kim CY
Oncol Rep; 2010 Jan; 23(1):113-9. PubMed ID: 19956871
[TBL] [Abstract][Full Text] [Related]
50. Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma.
Koschny R; Brost S; Hinz U; Sykora J; Batke EM; Singer S; Breuhahn K; Stremmel W; Walczak H; Schemmer P; Schirmacher P; Ganten TM
BMC Cancer; 2013 Nov; 13():532. PubMed ID: 24209510
[TBL] [Abstract][Full Text] [Related]
51. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8.
Fotin-Mleczek M; Henkler F; Samel D; Reichwein M; Hausser A; Parmryd I; Scheurich P; Schmid JA; Wajant H
J Cell Sci; 2002 Jul; 115(Pt 13):2757-70. PubMed ID: 12077366
[TBL] [Abstract][Full Text] [Related]
52. [Expression of caspase3 gene does not correlate with tumor cell apoptosis in primary hepatocellular carcinoma].
Sun B; Zhang J; Wang B
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):39-41. PubMed ID: 11776594
[TBL] [Abstract][Full Text] [Related]
53. Tumour necrosis factor-mediated cell death pathways do not contribute to muscle fibre death in dystrophinopathies.
Tews DS
Acta Neuropathol; 2005 Feb; 109(2):217-25. PubMed ID: 15791480
[TBL] [Abstract][Full Text] [Related]
54. Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro.
Jordan JF; Kociok N; Grisanti S; Jacobi PC; Esser JM; Luther TT; Krieglstein GK; Esser P
Graefes Arch Clin Exp Ophthalmol; 2001 Aug; 239(8):613-8. PubMed ID: 11585319
[TBL] [Abstract][Full Text] [Related]
55. Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma.
Yamashita Y; Shimada M; Tanaka S; Okamamoto M; Miyazaki J; Sugimachi K
Hum Gene Ther; 2002 Jan; 13(2):275-86. PubMed ID: 11812283
[TBL] [Abstract][Full Text] [Related]
56. CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7.
Wu F; Fujita J; Murota M; Li JQ; Ishida T; Nishioka M; Imaida Y; Kuriyama S
Int J Oncol; 2002 Aug; 21(2):441-5. PubMed ID: 12118343
[TBL] [Abstract][Full Text] [Related]
57. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) loss in canine mammary carcinoma.
Kim SH; Seung BJ; Bae MK; Lim HY; Cho SH; Sur JH
Vet Comp Oncol; 2022 Mar; 20(1):207-214. PubMed ID: 34423555
[TBL] [Abstract][Full Text] [Related]
58. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.
Rubio-Moscardo F; Blesa D; Mestre C; Siebert R; Balasas T; Benito A; Rosenwald A; Climent J; Martinez JI; Schilhabel M; Karran EL; Gesk S; Esteller M; deLeeuw R; Staudt LM; Fernandez-Luna JL; Pinkel D; Dyer MJ; Martinez-Climent JA
Blood; 2005 Nov; 106(9):3214-22. PubMed ID: 16051735
[TBL] [Abstract][Full Text] [Related]
59. Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway.
Secchiero P; Gonelli A; Mirandola P; Melloni E; Zamai L; Celeghini C; Milani D; Zauli G
Blood; 2002 Oct; 100(7):2421-9. PubMed ID: 12239152
[TBL] [Abstract][Full Text] [Related]
60. Antitumor effects of soluble TRAIL in human hepatocellular carcinoma.
He S; Chen Y; Chen X; Zhao Y; Wang H; Zhang W; Wang S
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):51-4. PubMed ID: 15934308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
